References
- Haslam R J. Role of adenosine diphosphate in the aggregation of human blood-platelets by thrombin and by fatty acids. Nature (Lond) 1964; 202: 765–8
- Moncada S, Vane J R, Whittle B JR. Relative potency of prostacyclin, prostaglandin E1 and D2 as inhibitors of platelet aggregation in several species. Proc Physiol Soc 1977; 2: 2p–4p
- Smith J B, Silver M J, Ingerman C M, Kocisis J J. Prostaglandin D2 inhibits the aggregation of human platelets. Thromb Res 1974; 5: 291–9
- Kloeze J. Nobel Symp Influence of prostaglandins on platelet adhesiveness and platelet aggregation. 1967, No. 2: 241–252
- Steer M, Salzman E W. Cyclic nucleotides in hemostasis and thrombosis. Adv Cycl Nucleotide Res 1980; 12: 71–109
- Maclntyre D E, Pollock W K, Shaw A M, Bush-Field M, MacMillan L J, McNicol A. Agonist-induced inositol phospholipid metabolism and Ca++ flux in human platelet activation. Adv Exp Med Biol 1985; 192: 127–44
- Fisher G J, Bakshian S, Baldassare J J. Activation of human platelets by ADP causes a rapid rise in cytosolic free calcium without hydrolysis of phosphoinositol-4,5-bisphosphonate. Biochem Biophys Res Commun 1985; 129: 958–64
- Tsien R Y, Pozzan T, Rink T J. Calcium homeo-stasis in intact lymphocytes: cytoplasmic free calcium monitored with a new intracellularly trapped fluorescent indicator. J Cell Biol 1982; 94: 335–40
- Hallam T J, Rink T J. Response to adenosine diphosphate in human platelets loaded with the fluorescent Ca2+ indicator quin2. J Physiol 1985; 368: 131–46
- Tsai W-J, Chen J-C, Wang C-T. Changes in both calcium pool size and morphology of human platelets incubated in various concentrations of calcium ion. Calcium-specific bleb formation on platelet-membrane surface. Biochimica et Biophysica Acta 1988; 940: 105–20
- Rink T J. Cytosolic calcium in platelet activation. Experientia 1988; 44: 97–100
- Pollock W K, Rink T J. Thrombin and ionomycin can raise platelet cytosolic Ca2+ to micromolar levels by discharge of internal Ca2+ stores: studies using fura-2. Biochem Biophys Res Commun 1986; 139: 308–14
- Hallam T J, Rink T J. Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett 1985; 186: 175–9
- Shio H, Ramwell P W. Effect of prostaglandin E2 and aspirin on the secondary aggregation of human platelets. Nature New Biol 1972; 236: 45–6
- Malmsten C J, Granström E, Samuelsson B. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets. Biochem Biophys Res Commun 1976; 68: 569–76
- Salzman E W, Kensler P C, Levine L. Cyclic 3′,5′-adenosine monophosphate in human blood platelets. IV. Regulatory role of cyclic AMP in platelet function. Ann NY Acad Sci 1972; 201: 61–71
- Cole B, Robison G A, Hartmann R C. Studies on the role of cyclic AMP in platelet function. Ann NY Acad Sci 1971; 185: 477–87
- DeSonza N J, Dohadwalla A N, Reden J. Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties. Medicinal Research Reviews 1983; 3: 201–19
- Feinstein M B, Egan J J, Sha'afi RI, White J. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin). Biochem Biophys Res Commun 1983; 113: 598–604